Edition:
United States

People: GlaxoSmithKline PLC (GSK)

GSK on New York Consolidated

42.36USD
29 Mar 2017
Change (% chg)

$-0.05 (-0.12%)
Prev Close
$42.41
Open
$42.17
Day's High
$42.45
Day's Low
$42.15
Volume
624,778
Avg. Vol
3,561,995
52-wk High
$45.58
52-wk Low
$37.20

Witty, Andrew 

Sir Andrew Philip Witty is no longer as Chief Executive Officer, Executive Director of GlaxoSmithKline PLC, effective 31st March 2017. He joined GSK in 1985. He joined GSK in 1985. He has worked in the UK, South Africa, the USA and Singapore in various senior roles. In 2003, he was appointed President of GSK Europe and joined GSK’s Corporate Executive Team. In 2003 he was awarded the Public Service Medal by the Government of Singapore and in August 2012 was also awarded the Public Service Star. In the 2012 New Year Honours list, he was awarded a Knighthood for services to the economy and to the UK pharmaceutical industry. He served as the Lead Non-Executive Board member for the Department of Business, Innovation and Skills to December 2013. He was also President of the European Federation of Pharmaceutical Industries and Associations until July 2013. Sir Andrew is a member of the UK Prime Minister’s Business Advisory Group and was appointed to the UK Business Ambassador Group in January 2014.

Basic Compensation

Total Annual Compensation, GBP 3,262,000
Restricted Stock Awards, GBP --
Long-Term Incentive Plans, GBP 2,831,000
All Other, GBP 568,000
Fiscal Year Total, GBP 6,661,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --